At a glance
- Company
- Yamaha Motor Co., Ltd.
- Ticker
- Tokyo: 7272
- Announcement
- Product
- Location
- Seattle, Washington, United States
Key figures
- Share of diagnoses attributed to rare cancers
- over 25%
- CELL HANDLER 2 deliveries to date
- third delivery
- Deliveries outside Japan
- first delivery outside of Japan
People
- Dr. Taran GujralAssociate Professor in the Human Biology Division and Director of TRACER at Fred Hutch
Products and programs
IWATA, June 16, 2025 -- Yamaha Motor Co., Ltd. (Tokyo: 7272) has delivered the CELL HANDLER 2 cell picking and imaging system, which contributes to the efficiency and precision of new drug development research and testing, to Fred Hutch Cancer Center, a cancer research institute located in Seattle, Washington, United States, where it is expected to be used for research into rare cancers. This is the third delivery of the CELL HANDLER 2 and the first delivery outside of Japan.
Fred Hutch is a pioneering nonprofit organization dedicated to cancer research and treatment in the United States. It is internationally recognized for its research into cancers, HIV/AIDS, and COVID-19. The CELL HANDLER 2 was recently delivered to the laboratory of Dr. Taran Gujral, Associate Professor in the Human Biology Division and Director of TRACER, the Transformative Rare Cancer Initiative at Fred Hutch. Rare cancers make up over 25% of all diagnoses but often lack timely diagnosis, research models, and standard-of-care treatments. Dr. Gujral's research addresses this by using advanced functional assays to identify FDA-approved drugs with the potential to become new therapeutics candidates. By automating the drug screening process, previously done manually, the CELL HANDLER 2 has the potential to streamline research workflows and help accelerate the discovery of potential therapies for these understudied and often overlooked diseases.
In March 2025, Yamaha Motor launched the CELL HANDLER 2 as the successor to the original CELL HANDLER cell picking and imaging system, which handles cells (or cell clusters)* and acquires data with high speed and precision. The CELL HANDLER 2 not only features the same high-speed high-accuracy picking functionality but also utilizes AI-powered automatic cell selection and automatically stitches together images of the area surrounding the cells to generate a tiled image. Additionally, it improves traceability by capturing images after cell suctioning. The CELL HANDLER 2 streamlines tasks in various research processes that require the handling of cells, enabling more precise operations and contributing to the creation of highly reliable data.
*Single cells or 3D cell structures, such as spheroids and organoids.
![]()
CELL HANDLER 2 delivered to Fred Hutch Cancer Center
If you detect any issues, problems, or errors in this press release content, kindly contact [email protected] to notify us (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). We will respond and rectify the situation in the next 8 hours.
In brief
Yamaha Motor says it has delivered its CELL HANDLER 2 cell-picking and imaging system to Fred Hutch Cancer Center in Seattle for research into rare cancers. The delivery is the system’s first outside Japan and its third overall. The equipment will be used in the laboratory of Dr. Taran Gujral, whose research uses functional assays to identify FDA-approved drugs that could be candidates for new treatments. Yamaha says the system automates drug screening that was previously performed manually, potentially streamlining research workflows. Launched in March 2025, CELL HANDLER 2 uses AI-assisted cell selection and can assemble images of the surrounding area into tiled images. It also captures images after cell suctioning, which Yamaha says improves traceability.
Key takeaways
- Yamaha Motor delivered CELL HANDLER 2 to Fred Hutch Cancer Center in Seattle.
- The delivery is the system’s first outside Japan and its third overall.
- The system is expected to support rare-cancer research in Dr. Taran Gujral’s laboratory.
- Yamaha says AI-assisted selection and imaging features can automate parts of research workflows.
Earlier from Yamaha Motor Co., Ltd.
- NMAX 125 Tech MAX Wins Red Dot Award -Yamaha Motor's record of Red Dot wins since 2012 extended to 14 years-
- Yamaha Motor to Continue Technical Partnership with Lola into Next Era of Formula E- Continuing the challenge to develop cutting-edge electric technologies at the standards expected of the world's premier all-electric racing series -
- Yamaha Motor Acquires Telwater, the Leading Australian Boat Manufacturer - Expanding sales networks and strengthening the foundations of the marine business -
- Yamaha Motor to Introduce New Next-Generation HARMO Boat Control System to Japanese Market - Integration with Helm Master(R) EX not only enhances maneuverability and convenience but also broadens compatibility with a wider range of vessels -
- Yamaha Motor to Participate in Sustainable Brands International Conference 2025 - Keynote Speeches, Product Exhibitions, and Electric Wheelchair Test Rides -